Novo Nordisk and Evotec selected three projects from Boston University, Harvard University in collaboration with Mass General Brigham, and Joslin Diabetes Center to be developed within LAB eN² focusing on cardiometabolic diseases.

A SEAS research team has developed a platform to manipulate qubits in silicon for quantum networks. This research was supported by AWS Center for Quantum Networking and the Harvard Quantum Initiative.

Harvard physicists demonstrate the first metro-area quantum computer network.

Northpond-funded Laboratory for Bioengineering Research and Innovation makes its fourth investment into the future of biotech.